Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice
Francisco Queipo(Complexo Hospitalario Universitario A Coruña), Carmen Beorlegui, Marina Álvarez Cortés(Hospital General San Jorge), Carmen María Bernal Mañas(Hospital General San Jorge), Elena Carceller Tejedor(Hospital General San Jorge), Gottfrid Sjödahl(Lund University), Arceli Bono Ariño(Hospital General San Jorge), Sandra Gracia Fuertes(Hospital General San Jorge), Gorka Muñiz Unamunzaga(Hospital General San Jorge), Begoña Fuertes Negro(Hospital Universitari de Girona Doctor Josep Trueta)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
June 22, 2022
Cited by 16
Related Papers
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k
A Molecular Taxonomy for Urothelial Carcinoma
|Clinical Cancer Research|2012|1k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386
Molecular classification of urothelial carcinoma: global <scp>mRNA</scp> classification versus tumour‐cell phenotype classification
|The Journal of Pathology|2017|368